Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: Relying on deep therapeutic area expertise, scientific knowledge, and a superior understanding of Medical Affairs and the compliant interplay with commercial brand teams, this role is responsible for leading the strategic development and overall tactical execution of dedicated late stage pipeline launch, as well as, all current on market indications with focus on Nephrology. This position is highly visible, collaborative, and influential and will serve as the integrated medical affairs representative for cross-functional senior leadership teams including but not limited to: Commercial Brand teams, Clinical Development, Government Affairs, Marketing, as well as developing and advancing relationships with select external KOLs This individual will report to the head of Medical Affairs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree
Number of Employees
251-500 employees